• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A newly DNA delivery system using biodegradable polymer for BMP therapy

Research Project

Project/Area Number 16591508
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Orthopaedic surgery
Research InstitutionOsaka City University

Principal Investigator

KAZUKI Kenichi (2005)  Osaka City University, Graduate School of Medicine, assistant professor, 大学院・医学研究科, 助教授 (80254407)

長山 隆一 (2004)  大阪市立大学, 大学院・医学研究科, 助手 (50336781)

Co-Investigator(Kenkyū-buntansha) TAKAOKA Kunio  Osaka City University, Graduate School of Medicine, professor, 大学院・医学研究科, 教授 (30112048)
香月 憲一  大阪市立大学, 大学院・医学研究科, 助教授 (80254407)
Project Period (FY) 2004 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2005: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2004: ¥3,200,000 (Direct Cost: ¥3,200,000)
Keywordspoly-D, L-lactic acid and polyethylene glycol (PLA-PEG) / Bone Morphogenetic Protein / Gene therapy
Research Abstract

We studied the effectiveness of gene transfer using the biodegradable polymer (PLA-PEG). Beta-galactosidase and luciferase were used to assess the efficiency of gene transfer into muscle in vivo. LacZ gene was inserted under the chick actin promoter on pCAGGS expression vector which were highly expressed the inserted gene in muscle cells. Luciferase was expressed using pGL3-control vector^<【○!R】> which was including SV40 promoter. In our previously studies, we demonstrated that cationic lipid lipofection, Lipofectamine 2000^<【○!R】> (LF2000) was effective to transfer the plasmids into cultured mesenchymal stem cells. In order to increase the gene transfer efficiency by PLA-PEG in vivo, we mixed LF2000 with PLA-PEG. To determine the effectiveness of PLA-PEG with or without LF2000 to transfer plasmids into muscle, the mice were divided into three groups based on pellets received, i.e., (1)45mg of PLA-PEG containing 15μl of LF2000 and 45μg of plasmids ; (2)45mg of PLA-PEG containing 45μg of plasmids ; and (3)45mg of PLA-PEG only. Under general anesthesia, the PLA-PEG containing plasmid was implanted into the left dorsal muscle pouches of mice. One week after implantation, the mice were sacrificed and the tissues around the implanted pellets were harvested. The expression level of β-galactosidase in pellets was histologically evaluated by X-gal and hematoxylin-eosin stains. In addition, luciferase activity in extracted specimens from pellets was measured.
X-gal stain in LF2000+ plasmids + PLA-PEG pellets was stronger than that in plasmids + PLA-PEG. In the histological study, the area of X-gal staining was located in the cells around the pellet but not in muscle cells. Positive cells with X-gal staining were similar with mesenchymal stem cells. The expression of luciferase in the LF2000+ DNA+ PLA-PEG pellet was higher than that in DNA+ PLA-PEG.

Report

(3 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • Research Products

    (11 results)

All 2006 2005 2004

All Journal Article (11 results)

  • [Journal Article] A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2: A potential treatment for infected bone defects.2006

    • Author(s)
      Suzuki A, et al.
    • Journal Title

      J Orthop Res 23

      Pages: 327-332

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2).2006

    • Author(s)
      Kato M, et al.
    • Journal Title

      Biomaterials 27

      Pages: 2035-2041

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Abiodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2 : A potential treatment for infected bone defects.2006

    • Author(s)
      Suzuki A, et al.
    • Journal Title

      J Orthop Res 23

      Pages: 327-332

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2).2006

    • Author(s)
      S Kato M, et al.
    • Journal Title

      Biomaterials 27

      Pages: 2035-2041

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2 : A potential treatment for infected bone defects.2006

    • Author(s)
      Suzuki A, et al.
    • Journal Title

      J Orthop Res 23

      Pages: 327-332

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model2005

    • Author(s)
      Namikawa T, et al.
    • Journal Title

      Spine 30

      Pages: 1717-1722

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist.2005

    • Author(s)
      Toyoda H, et al.
    • Journal Title

      Bone 37

      Pages: 555-562

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.2005

    • Author(s)
      Yoneda M, et al.
    • Journal Title

      Biomaterials 26

      Pages: 5145-5152

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.2005

    • Author(s)
      Namikawa T, et al.
    • Journal Title

      Spine 30

      Pages: 1717-1722

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Repair of an Intercalated Long Long Bone Defect with a Synthetic Biodegradable Bone-inducing Implant Biomaterials2005

    • Author(s)
      Yoneda M, Takaoka K, et al.
    • Journal Title

      Biomaterials (1月24日)(accept)

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Experimental Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2 Delivered by a Synthetic Polymer and Beta-Tricalcium Phosphate in a Rabbit Model2004

    • Author(s)
      Namikawa T, Takaoak K, et al.
    • Journal Title

      Spain (9月3日)(accept)

    • Related Report
      2004 Annual Research Report

URL: 

Published: 2004-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi